N-[1-[(1S,3R,7R,8R,10R)-5,5-dimethyl-13-phenyl-4,6,9,12,14-pentaoxatricyclo[8.4.0.03,7]tetradecan-8-yl]-2-oxopyrimidin-4-yl]benzamide

C28H29N3O7 — CID 58940360

IUPACN-[1-[(1S,3R,7R,8R,10R)-5,5-dimethyl-13-phenyl-4,6,9,12,14-pentaoxatricyclo[8.4.0.03,7]tetradecan-8-yl]-2-oxopyrimidin-4-yl]benzamide
SMILESCC1(C)O[C@H]2[C@H](n3ccc(NC(=O)c4ccccc4)nc3=O)O[C@@H]3COC(c4ccccc4)O[C@H]3C[C@H]2O1
InChIInChI=1S/C28H29N3O7/c1-28(2)37-20-15-19-21(16-34-26(36-19)18-11-7-4-8-12-18)35-25(23(20)38-28)31-14-13-22(30-27(31)33)29-24(32)17-9-5-3-6-10-17/h3-14,19-21,23,25-26H,15-16H2,1-2H3,(H,29,30,32,33)/t19-,20+,21+,23+,25+,26?/m0/s1
InChIKeyJBWLNRMCNHFGQP-AXKSEZRDSA-N
MW519.55 g/mol
LogP3.42
Rot. Bonds4

About N-[1-[(1S,3R,7R,8R,10R)-5,5-dimethyl-13-phenyl-4,6,9,12,14-pentaoxatricyclo[8.4.0.03,7]tetradecan-8-yl]-2-oxopyrimidin-4-yl]benzamide

N-[1-[(1S,3R,7R,8R,10R)-5,5-dimethyl-13-phenyl-4,6,9,12,14-pentaoxatricyclo[8.4.0.03,7]tetradecan-8-yl]-2-oxopyrimidin-4-yl]benzamide (PubChem CID 58940360) has the molecular formula C28H29N3O7 and a molecular weight of 519.55 g/mol. Its IUPAC name is N-[1-[(1S,3R,7R,8R,10R)-5,5-dimethyl-13-phenyl-4,6,9,12,14-pentaoxatricyclo[8.4.0.03,7]tetradecan-8-yl]-2-oxopyrimidin-4-yl]benzamide.

Molecular Properties

Compound NameN-[1-[(1S,3R,7R,8R,10R)-5,5-dimethyl-13-phenyl-4,6,9,12,14-pentaoxatricyclo[8.4.0.03,7]tetradecan-8-yl]-2-oxopyrimidin-4-yl]benzamide
PubChem CID58940360
Molecular FormulaC28H29N3O7
Molecular Weight519.55 g/mol
Exact Mass519.20
IUPAC NameN-[1-[(1S,3R,7R,8R,10R)-5,5-dimethyl-13-phenyl-4,6,9,12,14-pentaoxatricyclo[8.4.0.03,7]tetradecan-8-yl]-2-oxopyrimidin-4-yl]benzamide
SMILESCC1(C)O[C@H]2[C@H](n3ccc(NC(=O)c4ccccc4)nc3=O)O[C@@H]3COC(c4ccccc4)O[C@H]3C[C@H]2O1
InChIInChI=1S/C28H29N3O7/c1-28(2)37-20-15-19-21(16-34-26(36-19)18-11-7-4-8-12-18)35-25(23(20)38-28)31-14-13-22(30-27(31)33)29-24(32)17-9-5-3-6-10-17/h3-14,19-21,23,25-26H,15-16H2,1-2H3,(H,29,30,32,33)/t19-,20+,21+,23+,25+,26?/m0/s1
InChIKeyJBWLNRMCNHFGQP-AXKSEZRDSA-N
XLogP3.42
TPSA110.14 Ų
H-Bond Donors1
H-Bond Acceptors9
Rotatable Bonds4
Heavy Atoms38
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500519.55
LogP ≤ 53.42
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 109

Analyze N-[1-[(1S,3R,7R,8R,10R)-5,5-dimethyl-13-phenyl-4,6,9,12,14-pentaoxatricyclo[8.4.0.03,7]tetradecan-8-yl]-2-oxopyrimidin-4-yl]benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[1-[(1S,3R,7R,8R,10R)-5,5-dimethyl-13-phenyl-4,6,9,12,14-pentaoxatricyclo[8.4.0.03,7]tetradecan-8-yl]-2-oxopyrimidin-4-yl]benzamide?
The IUPAC name of N-[1-[(1S,3R,7R,8R,10R)-5,5-dimethyl-13-phenyl-4,6,9,12,14-pentaoxatricyclo[8.4.0.03,7]tetradecan-8-yl]-2-oxopyrimidin-4-yl]benzamide (CID 58940360) is N-[1-[(1S,3R,7R,8R,10R)-5,5-dimethyl-13-phenyl-4,6,9,12,14-pentaoxatricyclo[8.4.0.03,7]tetradecan-8-yl]-2-oxopyrimidin-4-yl]benzamide.
What is the SMILES notation for N-[1-[(1S,3R,7R,8R,10R)-5,5-dimethyl-13-phenyl-4,6,9,12,14-pentaoxatricyclo[8.4.0.03,7]tetradecan-8-yl]-2-oxopyrimidin-4-yl]benzamide?
The canonical SMILES for N-[1-[(1S,3R,7R,8R,10R)-5,5-dimethyl-13-phenyl-4,6,9,12,14-pentaoxatricyclo[8.4.0.03,7]tetradecan-8-yl]-2-oxopyrimidin-4-yl]benzamide is CC1(C)O[C@H]2[C@H](n3ccc(NC(=O)c4ccccc4)nc3=O)O[C@@H]3COC(c4ccccc4)O[C@H]3C[C@H]2O1.
What is the InChIKey of N-[1-[(1S,3R,7R,8R,10R)-5,5-dimethyl-13-phenyl-4,6,9,12,14-pentaoxatricyclo[8.4.0.03,7]tetradecan-8-yl]-2-oxopyrimidin-4-yl]benzamide?
The InChIKey is JBWLNRMCNHFGQP-AXKSEZRDSA-N. The full InChI is InChI=1S/C28H29N3O7/c1-28(2)37-20-15-19-21(16-34-26(36-19)18-11-7-4-8-12-18)35-25(23(20)38-28)31-14-13-22(30-27(31)33)29-24(32)17-9-5-3-6-10-17/h3-14,19-21,23,25-26H,15-16H2,1-2H3,(H,29,30,32,33)/t19-,20+,21+,23+,25+,26?/m0/s1.
What are the key properties of N-[1-[(1S,3R,7R,8R,10R)-5,5-dimethyl-13-phenyl-4,6,9,12,14-pentaoxatricyclo[8.4.0.03,7]tetradecan-8-yl]-2-oxopyrimidin-4-yl]benzamide?
N-[1-[(1S,3R,7R,8R,10R)-5,5-dimethyl-13-phenyl-4,6,9,12,14-pentaoxatricyclo[8.4.0.03,7]tetradecan-8-yl]-2-oxopyrimidin-4-yl]benzamide has a molecular weight of 519.55 g/mol, XLogP of 3.42, 4 rotatable bonds, 1 hydrogen bond donors, and 9 hydrogen bond acceptors.
Where does this data come from?
All data for N-[1-[(1S,3R,7R,8R,10R)-5,5-dimethyl-13-phenyl-4,6,9,12,14-pentaoxatricyclo[8.4.0.03,7]tetradecan-8-yl]-2-oxopyrimidin-4-yl]benzamide is sourced from PubChem (CID 58940360), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).